06.02.2024 - EDINBURGH, United Kingdom, Feb. 06, 2024 (GLOBE NEWSWIRE) - NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present and host one-on-one meetings at the Oppenheimer .
16.10.2023 - Data from the NuTide:701 Study Indicate NUC-7738 May Potentiate the Activity of Anti-PD-1 Agents in Patients who were Refractory to or Progressed on Prior Immunotherapy, including Anti-PD-1 Therapy Several Patients Achieved Reductions in Tumor . Seite 1
18.09.2023 - EDINBURGH, United Kingdom, Sept. 18, 2023 (GLOBE NEWSWIRE) - NuCana plc (NASDAQ: NCNA) announced four presentations at the upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 being held October 11-15, . Seite 1